Structural implications: From scarcity to access - GLP-1 therapies are moving from premium, niche treatments to mass-market chronic therapies
The differences between various active peptides stem from their unique amino acid sequences and structures, which determine their specific interactions with biological pathways
Each peptide is certified for authenticity, tested for purity above 99%, and produced in compliance with FDA guidelines
213 Red yeast rice extracts have also been shown to be well tolerated and effective in lowering LDL in patients with statin intolerance 214,215 and safe and effective in LDL-lowering even in younger individuals
Before enrolling in any telehealth GLP-1 program, consumers should review the platform's privacy policy, telehealth consent materials, and any medical group or technology partner disclosures